Cancer stem cells: advances in knowledge and implications for cancer therapy
X Chu, W Tian, J Ning, G Xiao, Y Zhou… - … and Targeted Therapy, 2024 - nature.com
Cancer stem cells (CSCs), a small subset of cells in tumors that are characterized by self-
renewal and continuous proliferation, lead to tumorigenesis, metastasis, and maintain tumor …
renewal and continuous proliferation, lead to tumorigenesis, metastasis, and maintain tumor …
Extracellular matrix and its therapeutic potential for cancer treatment
J Huang, L Zhang, D Wan, L Zhou, S Zheng… - … and Targeted Therapy, 2021 - nature.com
The extracellular matrix (ECM) is one of the major components of tumors that plays multiple
crucial roles, including mechanical support, modulation of the microenvironment, and a …
crucial roles, including mechanical support, modulation of the microenvironment, and a …
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
P Zheng, C Zhou, L Lu, B Liu, Y Ding - Journal of Experimental & Clinical …, 2022 - Springer
Elesclomol is an anticancer drug that targets mitochondrial metabolism. In the past,
elesclomol was recognized as an inducer of oxidative stress, but now it has also been found …
elesclomol was recognized as an inducer of oxidative stress, but now it has also been found …
[HTML][HTML] Dysregulated FOXM1 signaling in the regulation of cancer stem cells
Since the introduction of the cancer stem cell (CSC) paradigm, significant advances have
been made in understanding the functional and biological plasticity of these elusive …
been made in understanding the functional and biological plasticity of these elusive …
Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
CM Beaufort, JCA Helmijr, AM Piskorz, M Hoogstraat… - PloS one, 2014 - journals.plos.org
Epithelial ovarian cancer is a highly heterogeneous disease and remains the most lethal
gynaecological malignancy in the Western world. Therapeutic approaches need to account …
gynaecological malignancy in the Western world. Therapeutic approaches need to account …
The unique molecular and cellular microenvironment of ovarian cancer
T Worzfeld, E Pogge von Strandmann, M Huber… - Frontiers in …, 2017 - frontiersin.org
The reciprocal interplay of cancer cells and host cells is an indispensable prerequisite for
tumor growth and progression. Cells of both the innate and adaptive immune system, in …
tumor growth and progression. Cells of both the innate and adaptive immune system, in …
Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells
Four main histological subtypes of ovarian cancer exist: serous (the most frequent),
endometrioid, mucinous and clear cell; in each subtype, low and high grade. The large …
endometrioid, mucinous and clear cell; in each subtype, low and high grade. The large …
CD24: a novel target for cancer immunotherapy
E Panagiotou, NK Syrigos, A Charpidou… - Journal of Personalized …, 2022 - mdpi.com
Cluster of differentiation 24 (CD24) is a small, highly glycosylated cell adhesion protein that
is normally expressed by immune as well as epithelial, neural, and muscle cells. Tumor …
is normally expressed by immune as well as epithelial, neural, and muscle cells. Tumor …
Targeting cancer stem cells to overcome chemoresistance
Cancers are heterogeneous at the cell level, and the mechanisms leading to cancer
heterogeneity could be clonal evolution or cancer stem cells. Cancer stem cells are resistant …
heterogeneity could be clonal evolution or cancer stem cells. Cancer stem cells are resistant …
Cancer stem–like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production
T Hiraga, S Ito, H Nakamura - Cancer research, 2013 - AACR
CD44, an adhesion molecule that binds to the extracellular matrix, primarily to hyaluronan
(HA), has been implicated in cancer cell migration, invasion, and metastasis. CD44 has also …
(HA), has been implicated in cancer cell migration, invasion, and metastasis. CD44 has also …